The choice of first‐line palliative treatment has always been one of the crucial decisions in the management of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck not suitable for salvage surgery or full‐dose radiotherapy. This commentary highlights trial results that show the importance of treatment sequencing decisions that should be of interest for daily practice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571739 | PMC |
| http://dx.doi.org/10.1002/onco.13966 | DOI Listing |
Publication Analysis
Top Keywords
revisiting extreme
4
extreme immuno-oncology
4
immuno-oncology era
4
era improve
4
improve outcomes
4
outcomes choice
4
choice first‐line
4
first‐line palliative
4
palliative treatment
4
treatment crucial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!